Close



Mar 8, 2024 08:00AM
Nov 8, 2022 08:00AM
Nov 8, 2022 08:00AM
Jun 6, 2022 08:00AM
May 26, 2021 08:19AM
May 26, 2021 08:00AM
Apr 20, 2021 08:00AM Ovid Therapeutics Announces Appointment of Professor Robert S. Langer, Sc.D., as Chair of its Scientific Advisory Board
Mar 15, 2021 08:00AM
Mar 3, 2021 09:28AM
Dec 2, 2020 09:28AM
Dec 1, 2020 04:53PM
Dec 1, 2020 04:52PM
Nov 23, 2020 04:01PM
Nov 12, 2020 04:10PM Ovid Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Oct 14, 2020 07:00AM
Oct 12, 2020 07:00AM
Sep 30, 2020 08:05AM
Sep 30, 2020 08:00AM
Aug 25, 2020 09:30AM
Aug 10, 2020 08:00AM
Jul 23, 2020 07:00AM Ovid Therapeutics and University of Connecticut Enter into Strategic Research Collaboration to Accelerate the Development of Next-Generation Genetic Therapy for Angelman Syndrome
Jul 13, 2020 09:00AM
Jul 13, 2020 07:02AM
Jul 13, 2020 07:00AM
Jun 19, 2020 08:03AM
Jun 19, 2020 08:00AM
May 7, 2020 07:48AM
May 7, 2020 07:30AM Ovid Therapeutics Announces Positive Topline Results from the Phase 2 ROCKET Trial of OV101 for the Treatment of Fragile X Syndrome
Mar 30, 2020 08:00AM
Mar 11, 2020 08:00AM
Jan 7, 2020 08:03AM
Jan 7, 2020 08:00AM
Sep 23, 2019 07:07AM
Sep 23, 2019 07:00AM
Sep 23, 2019 07:00AM Ovid Therapeutics Announces Positive Initial Data from Ongoing ENDYMION Open-Label Extension Trial of Soticlestat in People with Rare Epilepsies
Sep 12, 2019 08:07AM
Sep 12, 2019 08:00AM
Sep 12, 2019 08:00AM
Sep 4, 2019 09:20AM
Aug 7, 2019 04:05PM
Aug 7, 2019 04:05PM
Jul 2, 2019 08:05AM Ovid Therapeutics (OVID) Receives Orphan Drug Designation from EC for OV101 for Treatment of Angelman Syndrome
Jul 2, 2019 08:00AM
Jul 2, 2019 08:00AM
Jun 27, 2019 08:09AM
Jun 27, 2019 08:00AM
Jun 27, 2019 08:00AM
May 23, 2019 04:50PM
Apr 18, 2019 08:00AM Ovid Therapeutics to Present at the American Academy of Neurology 71st Annual Meeting
Apr 18, 2019 08:00AM

251,648 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All